Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Restated Statements of Operations (Details)

v3.25.4
Schedule of Restated Statements of Operations (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Loss from Operations $ (3,382,000) $ (1,513,000) $ (3,445,000) $ (6,827,000) $ (12,422,000) $ (14,364,000)
Loss on initial recognition of Greenshoe Rights liability   (28,736,000) (28,736,000) (28,736,000) (28,736,000)
Change in fair value of Greenshoe Rights liability 11,413,000     11,413,000 (11,413,000)
Total Other Income (Expense) 11,681,000 (28,656,000) (27,500,000) (15,819,000) (15,932,000) 1,202,000
Net Loss 8,299,000 (30,169,000) (30,945,000) (22,646,000) (28,354,000) (13,162,000)
Dividend on Series L Preferred Stock (144,000) (85,000) (85,000) (229,000) (320,000)
Deemed dividend (4,058,000)     (4,058,000) (5,775,000)
Net Loss attributable to common stockholders’ $ 4,097,000 $ (30,254,000) $ (31,030,000) $ (26,933,000) $ (34,449,000) $ (13,162,000)
Net Loss Per Share - Basic $ 1.04 $ (10.92) $ (12.12) $ (8.90) $ (6.68) $ (6.94)
Net Loss Per Share - Diluted $ 1.04 $ (10.92) $ (12.12) $ (8.90) $ (6.68) $ (6.94)
Weighted average common shares outstanding - basic 3,940,714 2,771,765 2,559,604 3,025,033 5,513,255 1,897,375
Weighted average common shares outstanding - diluted 3,940,714 2,771,765 2,559,604 3,025,033 5,513,255 1,897,375
Previously Reported [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Loss from Operations $ (3,382,000) $ (1,513,000) $ (3,445,000) $ (6,827,000)    
Loss on initial recognition of Greenshoe Rights liability        
Change in fair value of Greenshoe Rights liability        
Total Other Income (Expense) 268,000 80,000 1,236,000 1,504,000    
Net Loss (3,114,000) (1,433,000) (2,209,000) (5,323,000)    
Dividend on Series L Preferred Stock (144,000) (85,000) (85,000) (229,000)    
Deemed dividend        
Net Loss attributable to common stockholders’ $ (3,258,000) $ (1,518,000) $ (2,294,000) $ (5,552,000)    
Net Loss Per Share - Basic $ (0.83) $ (0.55) $ (0.90) $ (1.84)    
Net Loss Per Share - Diluted $ (0.83) $ (0.55) $ (0.90) $ (1.84)    
Weighted average common shares outstanding - basic 3,940,714 2,771,765 2,559,604 3,025,033    
Weighted average common shares outstanding - diluted 3,940,714 2,771,765 2,559,604 3,025,033    
Revision of Prior Period, Adjustment [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Loss from Operations    
Loss on initial recognition of Greenshoe Rights liability   (28,736,000) (28,736,000) (28,736,000)    
Change in fair value of Greenshoe Rights liability 11,413,000     11,413,000    
Total Other Income (Expense) 11,413,000 (28,736,000) (28,736,000) (17,323,000)    
Net Loss 11,413,000 (28,736,000) (28,736,000) (17,323,000)    
Dividend on Series L Preferred Stock    
Deemed dividend (4,058,000)     (4,058,000)    
Net Loss attributable to common stockholders’ $ 7,355,000 $ (28,736,000) $ (28,736,000) $ (21,381,000)    
Net Loss Per Share - Basic $ 1.87 $ (10.37) $ (11.22) $ (7.06)    
Net Loss Per Share - Diluted $ 1.87 $ (10.37) $ (11.22) $ (7.06)    
Weighted average common shares outstanding - basic    
Weighted average common shares outstanding - diluted